Bristol-Myers Squibb Company

44.30 -0.62%
XETRA: BRM.DE
Market Cap.: 89.8 B L
P/E: -15.17 x34.54
EPS: -2.92 x -1.24
Earnings Call
1 month, 1 week from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 4.48%
Payout: 59.12%
Volume Level
μ 3,933
2,495 Moderate Low
Performance Ranks (Intraday)
United States:

1851st

out of

2160

Healthcare:

639th

out of

792

Drug Manufacturers—General:

48th

out of

62

Peer Group:

2nd

out of

5

About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for …